Latest news
BioMarin (BMRN) Is Up 6.3% After Raising 2026 Revenue Guidance And Highlighting Voxzogo Momentum - simplywall.stsimplywall.st · Sun, 09 Aug 2026 07:41:44 GMTIsrael Business News - Globes - Israel Business NewsGlobes - Israel Business News · Fri, 07 Aug 2026 07:00:00 GMTBioMarin Pharmaceutical 2Q 2026: Revenue $989.7M, EPS $0.23— 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:36:00 GMTBioMarin posts Q2 2026 revenue growth to $990M, raises full-year revenue and EPS guidance - TradingViewTradingView · Thu, 06 Aug 2026 20:13:22 GMT